BioCentury
ARTICLE | Company News

Miraculins, PreMD deal

August 16, 2010 7:00 AM UTC

Miraculins will acquire PreMD's Prevu Skin Cholesterol Test for C$250,000 (US$243,350) in cash and 1.8 million shares of Miraculins currently issued stock, valued at C$218,659 (US$212,843) based on Mi...